(Q58321557)

English

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

scientific article published on 01 July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

0 references

esophageal squamous cell carcinoma

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Li-Ru He

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Meng-Zhong Liu

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Bin-Kui Li

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Wei-Hua Jia

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ying Zhang

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Yi-Ji Liao

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Lan-Jun Zhang

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Yi-Xin Zeng

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Hsiang-Fu Kung

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Dan Xie

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

0 references

publication date

1 July 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

International Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

127

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

138-147

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Treatment of localized esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous rese

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Roles of the EZH2 histone methyltransferase in cancer epigenetics

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

The polycomb group protein EZH2 is involved in progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Control of developmental regulators by Polycomb in human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Activated p53 suppresses the histone methyltransferase EZH2 gene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Gamma-linolenic acid alters Ku80, E2F1, and bax expression and induces micronucleus formation in C6 glioma cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

A polycomb repression signature in metastatic prostate cancer predicts cancer outcome

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25031

21 January 2018

Identifiers

10.1002/IJC.25031

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19904743%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58321557&oldid=1758307253"